Sturla Magnus Grøndal

5PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.

|Dec 10, 2025
AXL Kinase Inhibition Promotes Cytosolic DNA Sensor cGAS Activity and Sensitizes Poorly Immunogenic Tumors to Chemo-Immunotherapy.

Sushil Dhakal, Muntequa I Siraji, Sturla M Grøndal

|Nov 20, 2025
AXL Kinase Inhibition Promotes Cytosolic DNA Sensor cGAS Activity and Sensitizes Poorly Immunogenic Tumors to Chemo-Immunotherapy.

Sushil Dhakal, Muntequa I Siraji, Sturla M Grøndal

|Jan 11, 2022
C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer.

Xiao-Zheng Liu, Anastasiia Rulina, Man Hung Choi

|Mar 03, 2021
High-dimensional immunotyping of tumors grown in obese and non-obese mice.

Cara E Wogsland, Hilde E Lien, Line Pedersen

Pageof 1

Frequent Collaborators

2 joint publications

Cara Ellen Wogsland

2 joint publications

Nils Halberg

2 joint publications

Sushil Dhakal

2 joint publications

Muntequa I Siraji